Filtered By:
Source: Urologic Oncology
Cancer: Androgen Independent Prostate Cancer
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
CONCLUSIONS: Our results demonstrate that Vav3 plays a crucial role in prostate cancer growth and malignant behavior, thus revealing a novel potential therapeutic target.
PMID: 23403204 [PubMed - as supplied by publisher]
Source: Urologic Oncology - February 8, 2013 Category: Urology & Nephrology Authors: Hirai K, Nomura T, Yamasaki M, Inoue T, Narimatsu T, Chisato Nakada PD, Yoshiyuki Tsukamoto PD, Matsuura K, Sato F, Moriyama M, Mimata H Tags: Urol Oncol Source Type: research
